| Name | Title | Contact Details |
|---|
Scientia Vascular offers access devices (microcatheters / guidewires) and therapies that are optimized to address the evolving needs of interventional specialists. Learn more about our next-generation solutions.
💉THE Leader in Regenerative Medicine 👉🏼Head of SSCI & @svlcatl 📞678-568-2309 ♻️We are a green company with one motto: save yourself, save the planet 🌍
Cannara plans to operate the largest indoor medical cannabis biotech facility in Quebec.
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi`s lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi recently initiated "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
A happier, healthier you is our goal. Kitsap Mental Health Services provides comprehensive, compassionate and people-centered care.